Department of Health (DOH) Regional Offices – CALABARZON (Cavite, Laguna, Batangas, Rizal, Quezon) and MIMAROPA (Oriental/Occidental Mindoro, Marinduque, Romblon, Palawan) held a joint blood drive yesterday, March 15, 2021 to boost the supply of blood products in the country which drastically declined to a critical level since the start of the pandemic.
A total of 39 personnel from CALABARZON and 13 from MIMAROPA participated in the mobile blood donation event held at the regional office in Project 4, Quezon City. There were 54 bags collected.
Also, a total of nine (9) successful apheresis donations were conducted (7 from CALABARZON region and 2 from MIMAROPA) wherein the process of separating blood into its different components: Platelets, Red Blood Cells (RBCs) and Plasma where obtain from the donors.
“The pandemic has caused a decline in the number of blood donations in the country due to the implementation of social distancing and the cancellation of blood drives. Yet the need for blood is consistent and growing lalo na ngayon at kaunti na lang ang nakakapagdonate,” DOH CALABARZON Regional Director Eduardo C. Janairo stated.
“We are encouraging the public to donate more blood through our mobile blood donation events. We need to have an adequate supply in all hospitals in the country especially now that we are still in pandemic. And we cannot only ensure this with the support of our donors,” he added.
DOH MIMAROPA Regional Director Mario S. Baquilod on his part, said that voluntary donors are recognized to be the safest donors because they are motivated by selflessness and the desire to help others and by a sense of moral duty or social responsibility.
According to Ms. Mayla A. Velgado, DOH-CALABARZON National Voluntary Blood Program Regional Coordinator, individuals diagnosed with COVID-19 also necessitates a blood transfusion, and those who recover from the virus could potentially help those who are currently infected by donating their convalescent plasma.
“Although it is still under clinical trial, the “plasma-derived therapy,” or “convalescent plasma,” is given to severe Covid-19 patients for “compassionate use”.